Clinical efficacy of Daikenchuto for gastrointestinal dysfunction following colon surgery: A randomized, double-blind, multicenter, placebo-controlled study (JFMC39-0902)

Japanese Journal of Clinical Oncology

Volumn 45, Issue 7, 2015, Pages 650-656

  Katsuno, Hidetoshi ^a   Maeda, Koutarou ^a   Kaiho, Takashi ^b   Kunieda, Katsuyuki ^c   Funahashi, Kimihiko ^d   Sakamoto, Junichi ^e   Kono, Toru ^f   Hasegawa, Hirotoshi ^g   Furukawa, Yoshiyuki ^h   Imazu, Yoshihiro ⁱ   Morita, Satoshi ^j   Watanabe, Masahiko ^k  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KIMITSU CHUO HOSPITAL   (Japan)

^c GIFU PREFECTURAL GIFU HOSPITAL   (Japan)

^d TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

^e Tokai Central Hospital of Japan Mutual Aid Association of Public School Teachers   (Japan)

^f Sapporo Higashi Tokushukai Hospital   (Japan)

^g KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h Kawasaki Hospital   (Japan)

ⁱ Shiba Daimon Imazu Clinic   (Japan)

^j KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^k KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

Bowel movement; Colon cancer; Daikenchuto; Herbal medicine

Indexed keywords

C REACTIVE PROTEIN; DAIKENCHUTO; HERBACEOUS AGENT; UNCLASSIFIED DRUG; DAI-KENCHU-TO; PLANT EXTRACT;

ABDOMINAL PAIN; ADULT; ARTICLE; CANCER STAGING; CLINICAL EFFECTIVENESS; COLON CANCER; COLON RESECTION; COLON SURGERY; CONTROLLED STUDY; DEFECATION; DIARRHEA; DIGESTIVE SYSTEM FUNCTION DISORDER; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FECES ANALYSIS; FEMALE; GASTROINTESTINAL TRACT FUNCTION; HUMAN; INCIDENCE; INTESTINE OBSTRUCTION; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; VOMITING; ADVERSE EFFECTS; AGED; CLINICAL TRIAL; COLONIC NEOPLASMS; DRUG EFFECTS; INTESTINE; JAPAN; MIDDLE AGED; PATHOPHYSIOLOGY; PERISTALSIS; TIME; TREATMENT OUTCOME;

ADULT; AGED; COLECTOMY; COLONIC NEOPLASMS; DEFECATION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTESTINES; JAPAN; MALE; MIDDLE AGED; PERISTALSIS; PLANT EXTRACTS; POSTOPERATIVE PERIOD; TIME FACTORS; TREATMENT OUTCOME;

EID: 84942017666     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyv056     Document Type: Article

References (31)

1. Luckey A, Livingston E, Tache Y. Mechanisms and treatment of postoperative ileus. Arch Surg 2003;138:206-14.
2. Livingston EH, Passaro EP Jr. Postoperative ileus. Dig Dis Sci 1990;35:121-32.
3. Fearon KC, Ljungqvist O, Von Meyenfeldt M, et al. Enhanced recovery after surgery: a consensus review of clinical care for patients undergoing colonic resection. Clin Nutr 2005;24:466-7.
4. Furukawa Y, Shiga Y, Hanyu N. Effect of Chinese herbal medicine on gastrointestinal motility and bowel obstruction. Jpn J Gastroenterol Surg 1995;28:956-60.
5. Itoh T, Yamakawa J, Mai M, et al. The effect of the herbal medicine dai-kenchu-to on post-operative ileus. J Int Med Res 2002;30:428-32.
6. Takeda T, Kamiura S, Kimura T. Effectiveness of the herbal medicine daikenchuto for radiation-induced enteritis. J Altern Complement Med 2008;14:753-5.
7. Shimada M, Morine Y, Nagano H, et al. Effect of tu-100, a traditional Japanese medicine, administered after hepatic resection in patients with liver cancer: A multi-center, phase III trial (JFMC40-1001). Int J Clin Oncol 2015;20:95-104.
8. Jin XL, Shibata C, Naito H, et al. Intraduodenal and intrajejunal administration of the herbal medicine, dai-kenchu-to, stimulates small intestinal motility via cholinergic receptors in conscious dogs. Dig Dis Sci 2001; 46:1171-6.
9. Nakamura T, Sakai A, Isogami I, et al. Abatement of morphine-induced slowing in gastrointestinal transit by dai-kenchu-to, a traditional Japanese herbal medicine. Jpn J Pharmacol 2001;88:217-21.
10. Satoh K, Kase Y, Yuzurihara M, et al. Effect of dai-kenchu-to (da-jian-zhong-tang) on the delayed intestinal propulsion induced by chlorpromazine in mice. J Ethnopharmacol 2003;86:37-44.
11. Tokita Y, Yuzurihara M, Sakaguchi M, et al. The pharmacological effects of daikenchuto, a traditional herbal medicine, on delayed gastrointestinal transit in rat postoperative ileus. J Pharmacol Sci 2007;104:303-10.
12. Satoh K, Hayakawa T, Kase Y, et al. Mechanisms for contractile effect of dai-kenchu-to in isolated guinea pig ileum. Dig Dis Sci 2001;46:250-6.
13. Manabe N, Camilleri M, Rao A, et al. Effect of daikenchuto (tu-100) on gastrointestinal and colonic transit in humans. Am J Physiol Gastrointest Liver Physiol 2010;298:G970-5.
14. Yoshikawa K, Shimada M, Nishioka M, et al. The effects of the kampo medicine (Japanese herbal medicine) "daikenchuto" on the surgical inflammatory response following laparoscopic colorectal resection. Surg Today 2012;42:646-51.
15. Ogasawara T, Morine Y, Ikemoto T, et al. Influence of dai-kenchu-to (dkt) on human portal blood flow. Hepatogastroenterology 2008;55:574-7.
16. Suehiro T, Matsumata T, Shikada Y, Sugimachi K. The effect of the herbal medicines dai-kenchu-to and keishi-bukuryo-gan on bowel movement after colorectal surgery. Hepatogastroenterology 2005;52:97-100.
17. Fukuda H, Chen C, Mantyh C, et al. The herbal medicine, dai-kenchu-to, accelerates delayed gastrointestinal transit after the operation in rats. J Surg Res 2006;131:290-5.
18. Shibata C, Sasaki I, Naito H, et al. The herbal medicine dai-kenchu-to stimulates upper gut motility through cholinergic and 5-hydroxytryptamine 3 receptors in conscious dogs. Surgery 1999;126:918-24.
19. Kono T, Koseki T, Chiba S, et al. Colonic vascular conductance increased by daikenchuto via calcitonin gene-related peptide and receptor-activity modifying protein 1. J Surg Res 2008;150:78-84.
20. Sato Y, Katagiri F, Inoue S, Itoh H, Takeyama M. Dai-kenchu-to raises levels of calcitonin gene-related peptide and substance p in human plasma. Biol Pharm Bull 2004;27:1875-7.
21. Sato Y, Inoue S, Katagiri F, et al. Effects of pirenzepine on dai-kenchuto-induced elevation of the plasma neuropeptide levels in humans. Biol Pharm Bull 2006;29:166-71.
22. Nagano T, Itoh H, Takeyama M. Effect of dai-kenchu-to on levels of 3 brain-gut peptides (motilin, gastrin and somatostatin) in human plasma. Biol Pharm Bull 1999;22:1131-3.
23. Nagano T, Itoh H, Takeyama M. Effects of dai-kenchu-to on levels of 5-hydroxytryptamine (serotonin) and vasoactive intestinal peptides in human plasma. Biol Pharm Bull 2000;23:352-3.
24. Munekage M, Kitagawa H, Ichikawa K, et al. Pharmacokinetics of daikenchuto, a traditional japanese medicine (kampo) after single oral administration to healthy japanese volunteers. Drug Metab Dispos 2011;39:1784-8.
25. Munekage M, Ichikawa K, Kitagawa H, et al. Population pharmacokinetic analysis of Daikenchuto, a traditional Japanese medicine (kampo) in Japanese and us health volunteers. Drug Metab Dispos 2013;41: 1256-63.
26. Kono T, Kanematsu T, Kitajima M. Exodus of kampo, traditional Japanese medicine, from the complementary and alternative medicines: is it time yet? Surgery 2009;146:837-40.
27. Kono T, Kaneko A, Omiya Y, et al. Epithelial transient receptor potential ankyrin 1 (trpa1)-dependent adrenomedullin upregulates blood flow in rat small intestine. Am J Physiol Gastrointest Liver Physiol 2013;304: G428-36.
28. Kono T, Omiya Y, Hira Y, et al. Daikenchuto (tu-100) ameliorates colon microvascular dysfunction via endogenous adrenomedullin in Crohn's disease rat model. J Gastroenterol 2011;6:1187-96.
29. Kono T, Kaneko A, Matsumoto C, et al. Multitargeted effects of hangeshashinto for treatment of chemotherapy-induced oral mucositis on inducible prostaglandin e2 production in human oral keratinocytes. Integr Cancer Ther 2014;13:435-45.
30. Hayakawa T, Kase Y, Saito K, et al. Effects of dai-kenchu-to on intestinal obstruction following laparotomy. J Smooth Muscle Res 1999;35: 47-54.
31. Yoshikawa K, Kurita N, Higashijima J, et al. Kampo medicine "dai-kenchu-to" prevents bacterial translocation in rats. Dig Dis Sci 2008;53:1824-31.